Fairvalue-Calculator Fairvalue-Calculator
EN DE

NFL Biosciences SA (ALNFL) Fair Value & Analysis

Healthcare · FR · Market cap €13.0M

Price€0.8650
Fair Value€0.1100
Upside-87.3%
Quality87/100
Evidence: Low Range €0.0800 – €0.1400

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

NFL Biosciences SA (ALNFL) currently trades at €0.8650, while our model-based Fair Value estimate is €0.1100 — implying the stock looks roughly 87.3% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company's pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is NFL Biosciences SA (ALNFL) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €0.1100 versus a price of €0.8650 — about −87% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALNFL?
Our 21-model fair value for NFL Biosciences SA is €0.1100 (as of Jun 24, 2026), built from audited fundamentals. The current price is €0.8650.
What is the quality score of ALNFL?
NFL Biosciences SA has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.